fbpx

Search for early diagnostic markers of brain cancer supported with ACRF funding

014_Directors_MIMR_356911ACRF-funded cutting edge technology is helping researchers at Melbourne’s MIMR-PHI Institute move closer to early diagnosis and treatment of Glioblastoma multiforme, an aggressive form of brain cancer.

More than 1,000 Australians are affected by Glioblastoma each year and most are not expected to live more than two years after diagnosis. Although researchers have come a long way in understanding and managing the disease, diagnosis and treatment remain a challenge.

Continue reading “Search for early diagnostic markers of brain cancer supported with ACRF funding”